Abstract:Highlights This study was the first to explore the association between the longitudinal changes in maternal serum ferritin with GDM. We found pregnant women that initially elevated ferritin levels can reduce their risk of GDM by lowering their ferritin levels in later stages of pregnancy. Routine iron supplementation may not be suitable for women with sufficient iron levels. Background The longitudinal changes in maternal serum ferritin (SF) levels across gestation, which indirectly reflect iron supplementation, have not been extensively investigated in relation to gestational diabetes mellitus (GDM). Methods We conducted a retrospective cohort study at a tertiary maternal hospital in Shanghai. Women with SF concentration measurements at 8.0–13.6 weeks' gestation (GW), 29.0–31.6 GW, and an oral glucose tolerance test (OGTT) at 24–28 GW were included. We utilized logistic regression analysis to assess GDM association with maternal SF levels and longitudinal changes. Results The study included 17 560 women, with 2160 (12.3%) participants diagnosed with GDM. Adjusted odds ratios (ORs) (95% confidence intervals [CIs]) for GDM across increasing quartiles of SF concentrations at 8.0–13.6 GW were 1.00 (reference), 1.139 (95% CI: 1.012–1.283), 1.093 (95% CI: 0.969–1.233), and 1.248 (95% CI: 1.111–1.403). Similarly, at 29.0–31.6 GW, increasing quartiles of SF concentrations were associated with higher adjusted ORs for GDM: 1.00 (reference), 1.165 (95% CI: 1.029–1.320), 1.335 (95% CI: 1.184–1.505), and 1.428 (95% CI: 1.268–1.607). Pregnant women with higher SF levels (upper 25th percentile) at 8.0–13.6 GW had a reduced GDM risk if their SF levels decreased to the lower 25th percentile at 29.0–31.6 GW. Conversely, the subgroup with higher SF levels (upper 25th percentile) at both time points had the highest incidence rate of GDM (15.3%, 1.235 [95% CI: 1.087–1.404]). Conclusions Maternal SF levels independently and positively associated with GDM risk during early and late gestational stages. Considering the increased GDM risk, routine iron supplementation for iron‐replete women is questionable.

Ferritin and iron supplements in gestational diabetes mellitus: less or more?

Hemoglobin Concentration and Iron Supplement During Pregnancy Were Associated with an Increased Risk of Gestational Diabetes Mellitus

The Association of Elevated Serum Ferritin Concentration in Early Pregnancy with Gestational Diabetes Mellitus: a Prospective Observational Study

Association between maternal plasma ferritin concentration, iron supplement use, and the risk of gestational diabetes: a prospective cohort study

Associations of maternal serum ferritin levels across gestation with gestational diabetes mellitus: A longitudinal cohort study

Iron Supplementation in Pregnancy and Risk of Gestational Diabetes: A Narrative Review

Association of mid-pregnancy ferritin levels with postpartum glucose metabolism in women with gestational diabetes

Dietary intake of heme iron and body iron status are associated with the risk of gestational diabetes mellitus: a systematic review and meta-analysis.

Periconceptional iron supplementation and risk of gestational diabetes mellitus: A prospective cohort study

A longitudinal study of iron status during pregnancy and the risk of gestational diabetes: findings from a prospective, multiracial cohort

Elevated hepcidin, ferroportin associated with glucose metabolism disorder in midpregnancy

Plasma Concentrations of Ferritin in Early Pregnancy Are Associated with Risk of Gestational Diabetes Mellitus in Women in the Danish National Birth Cohort

Associations of maternal serum concentration of iron-related indicators with gestational diabetes mellitus in Chinese: A pilot prospective cohort study

The Influence of Maternal Folate Status on Gestational Diabetes Mellitus: A Systematic Review and Meta-Analysis

High-Dose Folic Acid Supplement Use From Prepregnancy Through Midpregnancy Is Associated With Increased Risk of Gestational Diabetes Mellitus: A Prospective Cohort Study

effect of oral iron supplementation on glucose metabolism in non-anemic pregnant women who are in the risk group for gestational diabetes mellitus

The interactions between maternal iron supplementation and iron metabolism-related genetic polymorphisms on birth outcomes: a prospective study in Chinese

Maternal Supplementation with Multiple Micronutrients Containing Folic Acid Increased the Risk for Gestational Diabetes Mellitus: Results from a Prospective Cohort Study in China

Gestational diabetes mellitus affects placental iron homeostasis: Mechanism and clinical implications

Association of Folic Acid Supplementation in Early Pregnancy with Risk of Gestational Diabetes Mellitus: A Longitudinal Study